☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Rituxan
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
Chugai's Rozlytrek Receives MHLW's Approval for ROS1 Fusion-Positive Non-Small Cell Lung Cancer
February 21, 2020
Celltrion Reports Results of CT-P10 (rituximab- biosimilar) in P-III for Advance Follicular Lymphoma (AFL)
December 5, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
